These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10504500)

  • 1. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension.
    Vaziri ND; Liang K; Ding Y
    Kidney Int; 1999 Oct; 56(4):1492-8. PubMed ID: 10504500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase expression in the course of lead-induced hypertension.
    Vaziri ND; Ding Y; Ni Z
    Hypertension; 1999 Oct; 34(4 Pt 1):558-62. PubMed ID: 10523326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin C supplementation on oxidative DNA damage in an experimental model of lead-induced hypertension.
    Attri J; Dhawan V; Mahmood S; Pandhi P; Parwana HK; Nath R
    Ann Nutr Metab; 2003; 47(6):294-301. PubMed ID: 14520025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency.
    Vaziri ND; Ni Z; Oveisi F; Liang K; Pandian R
    Hypertension; 2002 Jan; 39(1):135-41. PubMed ID: 11799092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species.
    Koo JR; Vaziri ND
    Kidney Int; 2003 Jan; 63(1):195-201. PubMed ID: 12472783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension.
    Vaziri ND; Lin CY; Farmand F; Sindhu RK
    Kidney Int; 2003 Jan; 63(1):186-94. PubMed ID: 12472782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension.
    Barton CH; Ni Z; Vaziri ND
    Kidney Int; 2001 Sep; 60(3):1083-7. PubMed ID: 11532103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy.
    Vaziri ND; Ding Y; Ni Z; Gonick HC
    Kidney Int; 1997 Oct; 52(4):1042-6. PubMed ID: 9328943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet.
    Roberts CK; Vaziri ND; Wang XQ; Barnard RJ
    Hypertension; 2000 Sep; 36(3):423-9. PubMed ID: 10988276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase.
    Zhou XJ; Vaziri ND; Wang XQ; Silva FG; Laszik Z
    J Pharmacol Exp Ther; 2002 Mar; 300(3):762-7. PubMed ID: 11861779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
    Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
    Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside.
    Ding Y; Vaziri ND; Gonick HC
    Environ Res; 1998 Feb; 76(2):107-13. PubMed ID: 9515065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug.
    Vaziri ND; Ding Y; Ni Z
    J Pharmacol Exp Ther; 2001 Aug; 298(2):679-85. PubMed ID: 11454931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant treatment normalizes nitric oxide production, renal sodium handling and blood pressure in experimental hyperleptinemia.
    Beltowski J; Wójcicka G; Jamroz-Wiśniewska A; Borkowska E; Marciniak A
    Life Sci; 2005 Aug; 77(15):1855-68. PubMed ID: 15913657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats.
    Vaziri ND; Wang XQ; Oveisi F; Rad B
    Hypertension; 2000 Jul; 36(1):142-6. PubMed ID: 10904027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isohumulones derived from hops ameliorate renal injury via an anti-oxidative effect in Dahl salt-sensitive rats.
    Namikoshi T; Tomita N; Fujimoto S; Haruna Y; Ohzeki M; Komai N; Sasaki T; Yoshida A; Kashihara N
    Hypertens Res; 2007 Feb; 30(2):175-84. PubMed ID: 17460388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency.
    Vaziri ND; Dicus M; Ho ND; Boroujerdi-Rad L; Sindhu RK
    Kidney Int; 2003 Jan; 63(1):179-85. PubMed ID: 12472781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-fat, refined-carbohydrate diet affects renal NO synthase protein expression and salt sensitivity.
    Roberts CK; Vaziri ND; Sindhu RK; Barnard RJ
    J Appl Physiol (1985); 2003 Mar; 94(3):941-6. PubMed ID: 12433862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension.
    Ni Z; Bemanian S; Kivlighn SD; Vaziri ND
    Kidney Int; 1998 Jul; 54(1):188-92. PubMed ID: 9648078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The short-term consumption of a moderately high-fat diet alters nitric oxide bioavailability in lean female Zucker rats.
    Huang K; Huang Y; Frankel J; Addis C; Jaswani L; Wehner PS; Mangiarua EI; McCumbee WD
    Can J Physiol Pharmacol; 2011 Apr; 89(4):245-57. PubMed ID: 21539468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.